OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*
$118,175R01FY2006FDFDA
Cincinnati Childrens Hosp Med Ctr, Cincinnati OH
Investigators
Linked publications & trials
Abstract
Abstract Not Provided
View original record on NIH RePORTER →Cincinnati Childrens Hosp Med Ctr, Cincinnati OH
Abstract Not Provided
View original record on NIH RePORTER →